Sinopharm Group Co. Ltd. (HKG:1099)
Hong Kong · Delayed Price · Currency is HKD
21.70
+0.72 (3.43%)
Feb 23, 2026, 4:08 PM HKT
Revenue by Segment
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
| -22.86B | -20.77B | -18.50B | -15.91B | -13.10B | | | | | |
| 9.11B | 10.39B | 10.21B | 9.82B | 7.65B | | | | | |
| -12.32% | 1.73% | 3.95% | 28.35% | 51.91% | | | | | |
| 117.92B | 130.21B | 120.85B | 108.13B | 89.40B | | | | | |
| -9.44% | 7.75% | 11.77% | 20.95% | 29.02% | | | | | |
| 35.98B | 35.69B | 32.98B | 29.06B | 24.16B | | | | | |
| 0.82% | 8.22% | 13.49% | 20.26% | 22.02% | | | | | |
Pharmaceutical Distribution | 444.36B | 441.05B | 406.60B | 389.95B | 348.29B | | | | | |
Pharmaceutical Distribution Growth | 0.75% | 8.47% | 4.27% | 11.96% | 3.25% | | | | | |
| 584.51B | 596.57B | 552.15B | 521.05B | 456.41B | | | | | |
| -2.02% | 8.05% | 5.97% | 14.16% | 7.32% | | | | | |
Revenue by Geography
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
People's Republic of China (PRC) | 584.51B | 596.57B | 552.15B | 521.05B | 456.41B | | | | | |
People's Republic of China (PRC) Growth | -2.02% | 8.05% | 5.97% | 14.16% | 7.32% | | | | | |
| 584.51B | 596.57B | 552.15B | 521.05B | 456.41B | | | | | |
| -2.02% | 8.05% | 5.97% | 14.16% | 7.32% | | | | | |
Source: S&P Global Market Intelligence.